Aspire Biopharma Holdings, Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

1.350

-0.060 (-4.26%)

At close: Feb 11, 2026, 4:00 PM EST

1.310

-0.040 (-2.96%)

After-hours: Feb 11, 2026, 7:59 PM EST

Aspire Biopharma Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-20.54	-1.31	-0.36	-0.6
Change in Accounts Payable	0.04	0.25	0.05	0.1
Change in Other Net Operating Assets	0.89	0.8	0.32	0.35
Operating Cash Flow	-3.52	-0.27	0.01	-0.14
Sale (Purchase) of Intangibles	-	-	-	-4.9
Investing Cash Flow	-	-	-	-4.9
Issuance of Common Stock	-	-	-	1
Other Financing Activities	-0.64	-	-	3.85
Financing Cash Flow	5.45	0.26	-	4.85
Net Cash Flow	1.93	-0.01	0.01	-0.19
Cash Income Tax Paid	0	0	-	-
Levered Free Cash Flow	16.95	-0.68	-0.19	-
Unlevered Free Cash Flow	16.42	-0.62	-0.19	-
Change in Working Capital	0.9	1.04	0.37	0.45

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q